Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | |
|---|---|---|---|
| Operating cash flow (direct method) | |||
| Cash income from operating activities | -578.42K | ||
| Revenue from customers | ---- | ---- | ---578.42K |
| Cash paid | -134.69%-5.01M | -387.58%-2.13M | -437.42K |
| Payments to suppliers for goods and services | -87.85%-2.29M | ---1.22M | ---- |
| Other cash payments from operating activities | -197.20%-2.71M | -108.83%-913.47K | ---437.42K |
| Direct interest received | 767.30%203.35K | 82.60%23.45K | --12.84K |
| Operating cash flow | -127.65%-4.8M | -110.30%-2.11M | ---1M |
| Investing cash flow | |||
| Cash flow from continuing investing activities | 81.03%-13.01K | -68.6K | |
| Net PPE purchase and sale | 81.03%-13.01K | ---68.6K | ---- |
| Cash from discontinued investing activities | |||
| Investing cash flow | 81.03%-13.01K | ---68.6K | ---- |
| Financing cash flow | |||
| Cash flow from continuing financing activities | 343.20%9.14M | 1.69%2.06M | 2.03M |
| Net common stock issuance | 343.20%9.14M | 1.69%2.06M | --2.03M |
| Cash from discontinued financing activities | |||
| Financing cash flow | 343.20%9.14M | 1.69%2.06M | --2.03M |
| Net cash flow | |||
| Beginning cash position | -5.90%967.53K | --1.03M | ---- |
| Current changes in cash | 3,851.94%4.33M | -111.25%-115.31K | --1.03M |
| Effect of exchange rate changes | -454.91%-194.03K | 1,816.23%54.67K | --2.85K |
| End cash Position | 427.11%5.1M | -5.90%967.53K | --1.03M |
| Free cash from | -121.08%-4.81M | -117.14%-2.18M | ---1M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP |